An antisense oligonucleotide targeted to human Ku86 messenger RNA sensitizes M059K malignant glioma cells to ionizing radiation, bleomycin, and etoposide but not DNA cross-linking agents

Cancer Research

Volumn 62, Issue 20, 2002, Pages 5888-5896

  Belenkov, Alexandre I ^a   Paiement, Jean Pierre ^a   Panasci, Lawrence C ^c   Monia, Brett P ^d   Chow, Terry Y K ^a,b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BLEOMYCIN; CHLORAMBUCIL; CISPLATIN; ETOPOSIDE; KU 86 PROTEIN; KU ANTIGEN; MESSENGER RNA; PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CANCER RADIOTHERAPY; CELL DEATH; CELL LINE; CONTROLLED STUDY; DNA BINDING; DNA CROSS LINKING; DNA DAMAGE; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, NUCLEAR; ANTINEOPLASTIC AGENTS; BLEOMYCIN; CHLORAMBUCIL; CISPLATIN; DNA HELICASES; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; ETOPOSIDE; GLIOMA; HUMANS; KINETICS; NUCLEAR PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; SUBSTRATE SPECIFICITY; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037108857     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Smith, G. C., and Jackson, S. P. The DNA-dependent protein kinase. Genes Dev., 13: 916-934, 1999.
2. Featherstone, C., and Jackson, S. P. Ku, a DNA repair protein with multiple cellular functions? Mutat. Res., 434: 3-15, 1999.
3. Mimori, T., Akizuki, M., Yamagata, H., Inada, S., Yoshida, S., and Homma. M. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J. Clin. Investig., 68: 611-620, 1981.
4. Mimori, T., and Hardin, J. A. Mechanism of interaction between Ku protein and DNA. J. Biol. Chem., 261: 10375-10379, 1986.
5. Mimori, T., Hardin, J. A., and Steitz, J. A. Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. J. Biol. Chem., 261: 2274-2278, 1986.
6. Dvir, A., Peterson, S. R., Knuth, M. W., Lu, H., and Dynan, W. S. Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II. Proc. Natl. Acad. Sci. USA, 89: 11920-11924, 1992.
7. Gottlieb, T. M., and Jackson, S. P. The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen. Cell, 72: 131-142, 1993.
8. Morozov, V. E., Falzon, M., Anderson, C. W., and Kuff, E. L. DNA-dependent protein kinase is activated by nicks and larger single-stranded gaps. J. Biol. Chem., 269: 16684-16688, 1994.
9. Boubnov, N. V., Hall, K. T., Wills, Z., Lee, S. E., He, D. M., Benjamin, D. M., Pulaski, C. R., Band, H., Reeves, W. and Hendrickson, E. A. Complementation of the ionizing radiation sensitivity, DNA end binding, and V(D)J recombination defects of double-strand break repair mutants by the p86 Ku autoantigen. Proc. Natl. Acad. Sci. USA, 92: 890-894, 1995.
10. Chen, F., Peterson, S. R., Story, M. D., and Chen, D. J. Disruption of DNA-PK in Ku8O mutant xrs-6 and the implications in DNA double-strand break repair. Mutat. Res., 362: 9-19, 1996.
11. Hartley, K. O., Gell, D., Smith, G. C., Zhang, H., Divecha, N., Connelly, M. A., Admon, A., Lees-Miller, S. P., Anderson, C. W., and Jackson, S. P. DNA-dependent protein kinase catalytic subunit: A relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell, 82: 849-856, 1995.
12. Carter, T., Vancurova, I., Sun, I., Lou, W., and DeLeon, S. A DNA-activated protein kinase from HeLa cell nuclei. Mol. Cell. Biol., 10: 6460-6471, 1990.
13. Lees-Miller, S. P., Chen, Y. R., and Anderson, C. W. Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol. Cell. Biol., 10: 6472-6481, 1990.
14. Anderson, C. W., and Lees-Miller, S. P. The nuclear serine/threonine protein kinase DNA-PK. Crit Rev. Eukaryotic Gene Expression, 2: 283-314, 1992.
15. Anderson, C. W. DNA damage and the DNA-activated protein kinase. Trends Biochem. Sci., 18: 433-437, 1993.
16. Jackson, S. P., and Jeggo, P. A. DNA double-strand break repair and V(D)J recombination: Involvement of DNA-PK. Trends Biochem. Sci., 20: 412-415, 1995.
17. Jeggo, P. A., Taccioli, G. E., and Jackson, S. P. Menage à trois: Double strand break repair, V(D)J recombination and DNA-PK. Bioessays, 17: 949-957, 1995.
18. Klar, A. J., Strathern, J. N., and Abraham, J. A. Involvement of double-strand chromosomal breaks for mating-type switching in Saccharomyces cerevisiae. Cold Spring Harb. Symp. Quant. Biol., 49: 77-88, 1984.
19. Frankenberg-Schwager, M. Review of repair kinetics for DNA damage induced in eukaryotic cells in vitro by ionizing radiation. Radiother. Oncol., 14: 307-320, 1989.
20. Lieber, M. R., Hesse, J. E., Lewis, S., Bosma, G. C., Rosenberg, N., Mizuuchi, K., Bosma, M. J., and Gellert, M. The defect in murine severe combined immune deficiency: Joining of signal sequences but not coding segments in V(D)J recombination. Cell, 55: 7-16, 1988.
21. Fulop, G. M., and Phillips, R. A. The scid mutation in mice causes a general defect in DNA repair. Nature (Lond.), 347: 479-482, 1990.
22. Biedermann, K. A., Sun, J. R., Giaccia, A. J., Tosto, L. M., and Brown, J. M. scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc. Natl. Acad. Sci. USA, 88: 1394-1397, 1991.
23. Henner, W. D., Grunberg, S. M., and Haseltine, W. A. Enzyme action at 3′ termini of ionizing radiation-induced DNA strand breaks. J. Biol. Chem., 258: 15198-15205, 1983.
24. Radford, I. R. Evidence for a general relationship between the induced level of DNA double-strand breakage and cell-killing after X-irradiation of mammalian cells. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 49: 611-620, 1986.
25. Pergola, F., Zdzienicka, M. Z., and Lieber, M. R. V(D)J recombination in mammalian cell mutants defective in DNA double-strand break repair. Mol. Cell. Biol., 13: 3464-3471, 1993.
26. Taccioli, G. E., Rathbun, G., Oltz, E., Stamato, T., Jeggo, P. A., and Alt, F. W. Impairment of V(D)J recombination in double-strand break repair mutants. Science (Wash. DC), 260: 207-210, 1993.
27. Rathmell, W. K., and Chu, G. A DNA end-binding factor involved in double-strand break repair and V(D)J recombination. Mol. Cell. Biol., 14: 4741-4748, 1994.
28. Rathmell, W. K., and Chu, G. Involvement of the Ku autoantigen in the cellular response to DNA double-strand breaks. Proc. Natl. Acad. Sci. USA, 91: 7623-7627, 1994.
29. Getts, R. C., and Stamato, T. D. Absence of a Ku-like DNA end binding activity in the xrs double-strand DNA repair-deficient mutant. J. Biol. Chem., 269: 15981-15984, 1994.
30. Chen, D. J., Marrone, B. L., Nguyen, T., Stackhouse, M., Zhao, Y., and Siciliano, M. J. Regional assignment of a human DNA repair gene (XRCC5) to 2q35 by X-ray hybrid mapping. Genomics, 21: 423-427, 1994.
31. Hafezparast, M., Kaur, G. P., Zdzienicka. M., Athwal, R. S., Lehmann, A. R., and Jeggo, P. A. Subchromosomal localization of a gene (XRCC5) involved in double strand break repair to the region 2q34-36. Somat. Cell Mol. Genet., 19: 413-421, 1993.
32. Cai, Q. Q., Plet, A., Imbert, J., Lafage-Pochitaloff, M., Cerdan, C., and Blanchard, J. M. Chromosomal location and expression of the genes coding for Ku p70 and p80 in human cell lines and normal tissues. Cytogenet. Cell Genet., 65: 221-227, 1994.
33. Caldecott, K., and Jeggo, P. Cross-sensitivity of gamma-ray-sensitive hamster mutants to cross-linking agents. Mutat. Res., 255: 111-121, 1991.
34. Tanaka, T., Yamagami, T., Oka, Y., Nomura, T., and Sugiyama, H. The scid mutation in mice causes defects in the repair system for both double-strand DNA breaks and DNA cross-links. Mutat. Res., 288: 277-280, 1993.
35. Muller, C., Christodoulopoulos, G., Salles, B., and Panasci, L. DNA-dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards. Blood, 92: 2213-2219, 1998.
36. Christodoulopoulos, G., Muller, C., Salles, B., Kazmi, R., and Panasci, L. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin. Cancer Res., 58: 1789-1792, 1998.
37. Frit, P., Canitrot, Y., Muller, C., Foray, N., Calsou, P., Marangoni, E., Bourhis. J., and Salles, B. Cross-resistance to ionizing radiation in a murine leukemic cell line resistant to cis-dichlorodiammineplatinum(II): Role of Ku autoantigen. Mol. Pharmacol., 56: 141-146, 1999.
38. Allalunis-Turner, M. J., Lintott, L. G., Barron, G. M., Day, R. S., 111, and Lees-Miller, S. P. Lack of correlation between DNA-dependent protein kinase activity and tumor cell radiosensitivity. Cancer Res., 55: 5200-5202, 1995.
39. Kasten, U., Plottner, N., Johansen, J., Overgaard, J., and Dikomey, E. Ku70/80 gene expression and DNA-dependent protein kinase (DNA-PK) activity do not correlate with double-strand break (dsb) repair capacity and cellular radiosensitivity in normal human fibroblasts. Br. J. Cancer, 79: 1037-1041, 1999.
40. Klein, A., Miera, O., Bauer, O., Golfier, S., and Schriever, F. Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair. Leukemia (Baltimore), 14: 40-46, 2000.
41. Allalunis-Turner, M. J., Barron, G. M., Day, R. S., III, Dobler, K. D., and Mirzayans, R. Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiat. Res., 134: 349-354, 1993.
42. Lees-Miller, S. P., Godbout, R., Chan, D. W., Weinfeld, M., Day, R. S., III, Barron, G. M., and Allalunis-Turner. J. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science (Wash. DC), 267: 1183-1185, 1995.
43. Crooke, S. T. Molecular mechanisms of action of antisense drugs. Biochim. Biophys. Acta, 1489: 31-44, 1999.
44. Bennett, C. F., and Cowsert, L. M. Antisense oligonucleotides as a tool for gene functionalization and target validation. Biochim. Biophys. Acta, 1489: 19-30, 1999.
45. Baker, B. F., and Monia, B. P. Novel mechanisms for antisense-mediated regulation of gene expression. Biochim. Biophys. Acta, 1489: 3-18, 1999.
46. Mohammad, R. M., Mohamed, A. N., Hamdan, M. Y., Vo, T., Chen, B., Katato, K., Abubakr, Y. A., Dugan, M. C., and al Katib. A. Establishment of a human B-CLL xenograft model: Utility as a preclinical therapeutic model. Leukemia (Baltimore), 10: 130-137, 1996.
47. Chen, Z. P., Malapetsa, A., Mohr, G., Brien, S., and Panasci, L. C. Quantitation of ERCC-2 gene expression in human tumor cell lines by reverse transcription-polymerase chain reaction in comparison to northern blot analysis. Anal. Biochem., 244: 50-54, 1997.
48. Wells, D., and Kedes, L. Structure of a human histone cDNA: Evidence that basally expressed histone genes have intervening sequences and encode polyadenylated mRNAs. Proc. Natl. Acad. Sci. USA, 82: 2834-2838, 1985.
49. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
50. Monia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., McGee, D., Guinosso, C, J., Kawasaki, A. M., Cook, P. D., and Freier, S. M. Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem., 268: 14514-14522, 1993.
51. Ajmani, A. K., Satoh, M., Reap, E., Cohen, P. L., and Reeves, W. H. Absence of autoantigen Ku in mature human neutrophils and human promyelocytic leukemia line (HL-60) cells and lymphocytes undergoing apoptosis. J. Exp. Med., 181: 2049-2058, 1995.
52. Li, G., Nelsen, C., and Hendrickson, E. A. Ku86 is essential in human somatic cells. Proc. Natl. Acad. Sci. USA, 99: 832-837, 2002.
53. Moll, U., Lau, R., Sypes, M. A., Gupta, M. M., and Anderson, C. W. DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues. Oncogene, 18: 3114-3126, 1999.
54. Sadji, Z., Le Romancer. M., Lewin, M. J., and Reyl-Desmars, F. Human colon carcinoma cell-line HCT116 transfected by antisense cDNA as a tool to study the Ku86 involvement in cell proliferation. Cell Signalling, 12: 745-750, 2000.
55. Pucci, S., Mazzarelli, P., Rabitti, C., Giai, M., Gallucci, M., Flammia, G., Alcini, A., Altomare, V., and Fazio, V. M. Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies. Oncogene, 20: 739-747, 2001.
56. Kettunen, E., Nissen, A. M., Ollikainen, T., Taavitsainen, M., Tapper, J., Mattson, K., Linnainmaa, K., Knuutila, S., and El Rifai, W. Gene expression profiling of malignant mesothelioma cell lines: cDNA array study. Int. J. Cancer, 91: 492-496, 2001.
57. Lynch, E. M., Moreland, R. B., Ginis, I., Perrine, S. P., and Faller, D. V. Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro. Am. J. Physiol. Cell Physiol., 280: C897-C911, 2001.
58. Anderson, K. C. Novel biologically based therapies for myeloma. Cancer J., 7 (Suppl. 1): S19-S23, 2001.
59. Anderson, C. W., Dunn, J. J., Freimuth, P. I., Galloway, A. M., and Allalunis-Turner, M. J. Frameshift mutation in PRKDC, the gene for DNA-PKcs, in the DNA repairdefective, human, glioma-derived cell line M059J. Radiat. Res., 156: 2-9, 2001.
60. Ross, W. E., Glaubiger, D. L., and Kohn, K. W. Protein-associated DNA breaks in cells treated with Adriamycin or ellipticine. Biochim. Biophys. Acta. 519: 23-30, 1978.
61. Long, B. H., Musial. S. T., and Brattain, M. G. Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide. Cancer Res., 45: 3106-3112, 1985.
62. Jin, S., Inoue, S., and Weaver, D. T. Differential etoposide sensitivity of cells deficient in the Ku and DNA-PKcs components of the DNA-dependent protein kinase. Carcinogenesis (Lond.), 19: 965-971, 1998.
63. Boulton, S., Kyle, S., and Durkacz, B. W. Mechanisms of enhancement of cytotoxicity in etoposide and ionising radiation-treated cells by the protein kinase inhibitor wortmannin. Eur. J. Cancer, 36: 535-541, 2000.
64. Johnson, M. A., and Jones, N. J. The isolation and genetic analysis of V79-derived etoposide sensitive Chinese hamster cell mutants: Two new complementation groups of etoposide sensitive mutants. Mutat. Res., 435: 271-282, 1999.
65. Vogel, H., Lim, D. S., Karsenty, G., Finegold, M., and Hasty, P. Deletion of Ku86 causes early onset of senescence in mice. Proc. Natl. Acad. Sci. USA, 96: 10770-10775, 1999.
66. Bogue, M. A., Jhappan, C., and Roth, D. B. Analysis of variable (diversity) joining recombination in DNA-dependent protein kinase (DNA-PK)-deficient mice reveals DNA-PK-independent pathways for both signal and coding joint formation. Proc. Natl. Acad. Sci. USA, 95: 15559-15564, 1998.
67. Kulesza, P., and Lieber, M. R. DNA-PK is essential only for coding joint formation in V(D)J recombination. Nucleic Acids Res., 26: 3944-3948, 1998.
68. Guan, J., DiBiase, S., and Iliakis, G. The catalytic subunit DNA-dependent protein kinase (DNA-PKcs) facilitates recovery from radiation-induced inhibition of DNA replication. Nucleic Acids Res., 28: 1183-1192, 2000.
69. Larminat, F., Zhen, W., and Bohr, V. A. Gene-specific DNA repair of interstrand cross-links induced by chemotherapeutic agents can be preferential. J. Biol. Chem., 268: 2649-2654, 1993.
70. Panasci, L., Paiement, J. P., Christodoulopoulos, G., Belenkov, A., Malapetsa, A., and Aloyz, R. Chlorambucil drug resistance in chronic lymphocytic leukemia: The emerging role of DNA repair. Clin. Cancer Res., 7: 454-461, 2001.
71. Allalunis-Turner, J., Barron, G. M., and Day, R. S., III Intact G2-phase checkpoint in cells of a human cell line lacking DNA-dependent protein kinase activity. Radiat. Res., 147: 284-287, 1997.
72. Anderson, C. W., and Allalunis-Tumer, M. J. Human TP53 from the malignant glioma-derived cell lines M059J and M059K has a cancer-associated mutation in exon 8. Radiat. Res., 154: 473-476, 2000.
73. Higgins, N. P., and Cozzarelii, N. R. DNA-joining enzymes: A review. Methods Enzymol., 68: 50-71, 1979.
74. Celis, J. E., Madsen, P., Nielsen, S., Petersen, R. G., Lauridsen, J. B., and Celis, A. Levels of synthesis of primate-specific nuclear proteins differ between growth-arrested and proliferating cells. Exp. Cell Res., 168: 389-401, 1987.
75. Marangoni, E., Le Romancer, M., Foray, N., Muller, C., Douc-Rasy, S., Vaganay, S., Abdulkarim, B., Barrois, M., Calsou, P., Bernier, J., Salles, B., and Bourhis, J. Transfer of Ku86 RNA antisense decreases the radioresistance of human fibroblasts. Cancer Gene Ther., 7: 339-346, 2000.